Photocure (NO: PHOTO)

Last close As at 27/03/2024

150.90

0.00 (0.00%)

Market capitalisation

4,048m

Edison Investment Research is terminating coverage on Photocure. Please note you should no longer rely on any previous research or estimates for this company. All forecasts should now be considered redundant.

Previously published reports can still be accessed via our website.

Latest Insights

View More

Healthcare | Update

Photocure — Buying back rights from Ipsen

Healthcare | Update

Photocure — Firing on all cylinders

Healthcare | Update

Photocure — US sales up 53% compared to last year

Healthcare | Update

Photocure — US continues to be the driver

Financials

Edison Investment Research is terminating coverage on Photocure. Please note you should no longer rely on any previous research or estimates for this company. All forecasts should now be considered redundant.

Previously published reports can still be accessed via our website.

Research

Update

Healthcare

Photocure — US continues to be the driver

Update

Healthcare

Photocure — A licensing deal for Cevira

Update

Healthcare

Photocure — A strong quarter

Outlook

Healthcare

Photocure — Rapid acceleration in the US market

Update

Healthcare

Photocure — Strong revenue growth

Update

Healthcare

Photocure — US growth accelerating

research

Healthcare

Photocure — Solid growth in the US

Update

Healthcare

Photocure — Q4 results and a new indication

Thematics

thematic

Healthcare

Deutsches Eigenkapitalforum (EKF) 2023 healthcare

volition01

thematic

Healthcare

VolitionRx – Decoding the DNA of cancer 

thematic

Healthcare

ASCO 2023 key takeaways

Subscribe to Edison

Get access to the very latest content matched to your personal investment style.

Sign up for free